<!DOCTYPE html> 
 <!--[if lt IE 7]> <html lang="en" class="ie ie6 lte9 lte8 lte7 os-other"> <![endif]-->
 <!--[if IE 7]> <html lang="en" class="ie ie7 lte9 lte8 lte7 os-other"> <![endif]-->
 <!--[if IE 8]> <html lang="en" class="ie ie8 lte9 lte8 os-other"> <![endif]-->
 <!--[if IE 9]> <html lang="en" class="ie ie9 lte9 os-other"> <![endif]-->
 <!--[if gt IE 9]> <html lang="en" class="os-other"> <![endif]-->
 <!--[if !IE]><!--> <html lang="en" class="os-other"> <!--<![endif]-->

<head>


      
      
      
      
      
      
      
    



     
      
  
  

    
      
        
          
            
                
              
          
        
      
    
    


     
      
  

    
      
        
          
            
                
              
          
        
      
    
    



  <meta name="lnkd-track-json-lib" content="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=2jds9coeh4w78ed9wblscv68v-eo3jgzogk6v7maxgg86f4u27d&amp;fc=2">
  <meta name="lnkd-track-lib" content="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=eo3jgzogk6v7maxgg86f4u27d&amp;fc=2">




  
    <meta name="treeID" content="gIfEEq17JhMwoaZdESsAAA==">
  



  <meta name="appName" content="profile">


<meta name="lnkd-track-error" content="/lite/ua/error?csrfToken=ajax%3A8638745680363916939&amp;goback=%2Enppvan_markbanderson">


     
      
  
  
  
  

    
      
        
          
            
                
                  
                    <script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=8swqmpmjehppqzovz8zzfvv9g-aef5jooigi7oiyblwlouo8z90-e2u0uzhuvp24qrred2yekckx1-10q339fub5b718xk0pv9lzhpl&amp;fc=2"></script>
                  
                  
                
              
          
        
      
    
    



 <meta http-equiv="content-type" content="text/html; charset=UTF-8">
 <meta http-equiv="X-UA-Compatible" content="IE=8">
 <meta name="description" content="View Mark Brian Anderson, PhD, RAC's professional profile on LinkedIn.  LinkedIn is the world's largest business network, helping professionals like Mark Brian Anderson, PhD, RAC discover inside connections to recommended job candidates, industry experts, and business partners.">
 <meta name="pageImpressionID" content="0eb25505-a0be-45f3-bfbc-fe0fe12ae1f4">
 <meta name="pageKey" content="nprofile-public-success" >
 <meta name="analyticsURL" content="/analytics/noauthtracker">

 
 
<link rel="apple-touch-icon-precomposed" href="/img/icon/apple-touch-icon.png">
<!--[if lte IE 8]>
  <link rel="shortcut icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/16x16/favicon.ico">
<![endif]-->
<!--[if IE 9]>
  <link rel="shortcut icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/favicon.ico">
<![endif]-->
<link rel="icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/favicon.ico">


<meta name="msapplication-TileImage" content="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicon_w8_tile.png"/>
<meta name="msapplication-TileColor" content="#0077B5"/>
<meta name="application-name" content="LinkedIn"/>

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 <link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=3bifs78lai5i0ndyj1ew7316e-2ls5j5cdjrujv4sqdb0z16lmh-2it1to3q1pt5evainys9ta07p-4uu2pkz5u0jch61r2nhpyyrn8-ee859529mdos6retehcmn9z8a-7poavrvxlvh0irzkbnoyoginp-4om4nn3a2z730xs82d78xj3be-4mtnezjah7m1dorg1ys1puyqz-ct4kfyj4tquup0bvqhttvymms-9zbbsrdszts09by60it4vuo3q-bjn9kbvacgrovgpk6in831zk8-8ti9u6z5f55pestwbmte40d9-9x2uxeluz13xxpss2v8op0phx-cxff0g818hf3ks7dzixd4lqcq-2d3dmhru4d3a2ekwmxrg5bwd3&amp;fc=2">
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 <script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=dfoaudjrk6rbf82f45bz5crwi-62og8s54488owngg0s7escdit-c8ha6zrgpgcni7poa5ctye7il-djim7uyllidc9gta745y2wo5m-51dv6schthjydhvcv6rxvospp-d7z5zqt26qe7ht91f8494hqx5-e9rsfv7b5gx0bk0tln31dx3sq-2r5gveucqe4lsolc3n0oljsn1-8v2hz0euzy8m1tk5d6tfrn6j-b88qxy99s08xoes3weacd08uc-bymlr3eiytxzjg9or01ze5ia8-ac8pg92mfnb2j836ntpvg1fsi-a75npl1uw7jvxtd6tpgps2gw3-lyi4ca0d33mbzhvnuf1wvqjp-80pbsa4obuk9pkni9fepx3r1u-b0otj9zjsih2zu4s3gxjejik2-8gnadkog4qjkvf7alm205sobz-3ns2d4ano7knp93wdj2zg3drz-65r02rf4fgqf3q3s7b42u1w0z-1pa3tpaab6s85oxj5wgz5m0p7&amp;fc=2"></script>
 
 
  

          
          
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

          
          
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 
 

 
 

 
 
 
 
 
 
 
 <script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=6b5tomv24hymqjdn9yh9vdxyg-95d8d303rtd0n9wj4dcjbnh2c&amp;fc=2"></script>
 
 

<title>Mark Brian Anderson, PhD, RAC  | LinkedIn</title>

          
        

        
      
      
      
      
        
      
    
      
        
      
    
  

  
  
  
     
    
    
    
    
    
		
			
			
		
    

    
      
    
  
     
      
        
          
            
                
                  
                  
                    <link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=4p2lr3v1stqdryp7cwmzusws3-bubc6rv5t8u1olw8jqdcmcsxx-2f80q3wku8xajybx85i5jg69w-5xxmkfcm1ny97biv0pwj7ch69-bh4epi2lmzdt5u7j34vbgtyn&amp;fc=2">
                  
                
              
          
        
      
    
     
  
     
      
    
    
    
    
    
    
  
    
      
        
          
            
                
                  
                    <script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=alwisf9y2dgcx9durselvuryg-ew7wxbzv14lsc4vzkh2xrbzqn-dym7zp2dihe7sffiofjsa8c2n-cy4lqo5zy7pd10f5x6q2mcbav-1tcbnhkiqjn5ocajdluwwguus&amp;fc=2"></script>
                  
                  
                
              
          
        
      
    
    

      
      
      
        
      
    
      
      
    
      
      
    
      
      
    
      
      
    
      
      
    
      
      
    
      
     
      
      
     
    
      
        
          
            
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      

      
        
      


















            
          
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
</head>
        
      
      
      
      
        
      
    
    

  
      
      
      
        
      
    
      
        

        
          

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 
 

 
 

 
 







<body class="en guest v2 public-profile chrome-v5 chrome-v5-responsive background-v4 sticky-bg guest" id="pagekey-nprofile-public-success">

 
 
 
 
 
 







 <input id="inSlowConfig" type="hidden" value="false" />

<script type="text/javascript">document.body.className += " js ";</script>


          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




<div id="header">
 <div class="wrapper">
 <div id="nav-utility">
 <div class="logo" id="logo-linkedin">
 <a href="/home?trk=hb_logo" id="logo-href"><img src="http://s.c.lnkd.licdn.com/scds/common/u/img/logos/logo_linkedin_92x22.png" width="92" height="22" alt="LinkedIn"></a>
 </div>
 <ul class="menu">
 <li id="nav-utility-join"><a href="https://www.linkedin.com/reg/join?trk=hb_join">Join Today</a></li>
 <li id="nav-utility-auth"><a href="https://www.linkedin.com/uas/login?trk=hb_signin">Sign In</a></li>
 </ul>
 </div>
 </div> </div>

<div id="body">

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 

 
 

 <div class="wrapper">
 
 
 
 
 
 
 
 
 


 
 
 

 
 

<div id="global-error">
</div>




        

        
      
    
  
      
      

      
        
      



      
      
      
      
        
      
    
      
    
      

      <div id="main" class="profile grid-a">

        

        
        <div id="content" class="resume hresume">
          <div class="profile-header">
						<div id="member-1" class="masthead vcard contact">
            
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      




















  
  
  
      <div class="image zoomable" style="display:block" id="profile-picture">
        
            
                 <img src="http://m.c.lnkd.licdn.com/mpr/pub/image-uQlqTEAyKwCvdOGU0FNIl0IR55p1hfGt_wNQlCs65e0VT3hWuQlQzv4y5oYfhtSnEacu/mark-brian-anderson-phd-rac.jpg" class="photo" width="100" height="100" alt="Mark Brian Anderson, PhD, RAC">
              
          
		</div>
	
  
  
      <h1>

      
        

        
            <span id="name" class="n fn">
              <span class="full-name"><span class="given-name">Mark Brian</span> <span class="family-name">Anderson, PhD, RAC</span></span>
            </span>

          
          
          

      
        

      </h1>
    

  
  
    
      <span class="phonetic-full-name">
      
      </span>
    
  

  
  
    <p class="headline-title title" style="display:block">
    
    
        Contract Consulting &amp; President at Biotech Pharma Solutions
      
    
    </p>
  
  
  
       
     
  
  <dl id="headline" class="demographic-info adr">
    <dt>Location</dt>
    <dd>
    <span class="locality">
    
        
          
	      Greater Boston Area
            
	    
      
    </span>
    
    </dd>
    
    <dt>Industry</dt>
        <dd class="industry">
    
            Pharmaceuticals
      
    </dd>
    
  </dl>
  
       
     
      












            </div>
            
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      


      
    
  
      
      

      
        
      











<div id="nprofile-overview" class="join-linkedin name-button">
  <div class="header">

    <h2>
      <a href="https://www.linkedin.com/reg/join-pprofile?_ed=0_dHB8G4tKSI1eNkyEd3uBk2dzQE2AkVU1r9kHbXjxPZGWJlD5Jt4ZMf87SacJnJbVz3FvboiOjm93-w4_iUXBUaaUVPpLbhTl6Xdvdx-wj3u&amp;trk=pprof-0-ts-view_full-0" rel="nofollow">
          Join LinkedIn and access Mark Brian Anderson, PhD, RAC&#8217;s full profile. It's free!
      </a>
    </h2>
  </div>
  <div class="content">
    <p>As a LinkedIn member, you'll join 225 million other professionals who are sharing connections, ideas, and opportunities.</p>
    
      <ul>
        <li>See who you and <strong>Mark Brian Anderson, PhD, RAC</strong> know in common</li>
        <li>Get introduced to <strong>Mark Brian Anderson, PhD, RAC</strong></li>
        <li>Contact <strong>Mark Brian Anderson, PhD, RAC</strong> directly</li>
      </ul>
    
  </div>

  

  
    <p id="show-expanded" class="actions ">
      
        <a class="btn-action" id="regform-show" href="https://www.linkedin.com/reg/join-pprofile?_ed=0_dHB8G4tKSI1eNkyEd3uBk2dzQE2AkVU1r9kHbXjxPZGWJlD5Jt4ZMf87SacJnJbVz3FvboiOjm93-w4_iUXBUaaUVPpLbhTl6Xdvdx-wj3u&amp;trk=pprof-0-ts-view_full-0" rel="nofollow">
          View Mark Brian's full profile
        </a>
        
      
    </p>
  

  

  
</div>













              

            

          </div>

          

          

          
            
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      


















<h2 class="section-title">Mark Brian Anderson, PhD, RAC's Overview </h2>
<dl id="overview">
  
  
  <dt id="overview-summary-current-title" class="summary-current" style="display:block">
    Current
  </dt>
  <dd class="summary-current" style="display:block">
    
        <ul class="current">
			    
			      <li>
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Biotech Pharma Solutions (BPS) Nutrafortified
      
    
    
      <span class="at">at </span>
      Nutrafortified
    
	








			        
			      </li>
			    
			      <li>
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Biotech Pharma Solutions (BPS) Contract Consultant General
      
    
    
      <span class="at">at </span>
      
          <a class="company-profile-public" href="/company/biotech-pharma-solutions?trk=ppro_cprof"><span class="org summary">Biotech Pharma Solutions</span></a>
        
    
	








			        
			      </li>
			    
			      <li>
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Biotech Pharma Solutions (BPS) MNOW Experts Consult
      
    
    
      <span class="at">at </span>
      MNOW&#x2122; Experts
    
	








			        
			      </li>
			    
        </ul>
		    
		    
			  
      
  </dd>
  

  
  
  <dt id="overview-summary-past-title" class="summary-past" style="display:block">  
    Past
  </dt>
  <dd class="summary-past" style="display:block">
    
        <ul class="past">
		    
		      <li>
		        
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Biotech Pharma Solutions (BPS) NovaBay Pharmaceuticals Consult
      
    
    
      <span class="at">at </span>
      NovaBay Pharmaceuticals
    
	








		      </li>
		    
		      <li>
		        
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Biotech Pharma Solutions (BPS) Startups &amp; CRO Consult
      
    
    
      <span class="at">at </span>
      Startups, Biotech and Pharma
    
	








		      </li>
		    
		      <li>
		        
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Biotech Pharma Solutions (BPS) NovaBay Pharmaceuticals Chief Scientific Officer
      
    
    
      <span class="at">at </span>
      
          <a class="company-profile-public" href="/company/novabay-pharmaceuticals?trk=ppro_cprof"><span class="org summary">NovaBay Pharmaceuticals</span></a>
        
    
	








		      </li>
		    
		    </ul>
		    
        
        
          <div class="showhide-block" id="morepast">
            <ul class="past">
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Vice President at Myriad Genecics/Myriad Pharmaceuticals
      
    
    
      <span class="at">at </span>
      
          <a class="company-profile-public" href="/company/myriad-genetics?trk=ppro_cprof"><span class="org summary">Myriad Genetics-Pharmaceuticals</span></a>
        
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Senior Director at Elitra Pharmaceuticals
      
    
    
      <span class="at">at </span>
      Elitra Pharmaceuticals
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Associate Director Medicinal Chemistry at Pfizer-Agouron
      
    
    
      <span class="at">at </span>
      
          <a class="company-profile-public" href="/company/pfizer?trk=ppro_cprof"><span class="org summary">Pfizer - Agouron Pharmaceuticals</span></a>
        
    
	








                </li>
              
                <li>
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      














    
    
    Senior Research Scientist / International Project Leader
      
    
    
      <span class="at">at </span>
      
          <a class="company-profile-public" href="/company/ligand-pharmaceuticals?trk=ppro_cprof"><span class="org summary">Ligand Pharmaceuticals - Glycomed Incorporated</span></a>
        
    
	








                </li>
              
            </ul>
            <p class="seeall showhide-link"><a href="#" id="morepast-hide">see less</a></p>
          </div>
          <p class="seeall showhide-link"><a href="#" id="morepast-show">see all</a></p>
      
      
  </dd>
  

  
  
    <dt id="overview-summary-education-title" class="summary-education" style="display:block"> 
       Education
    </dt>
    <dd class="summary-education" style="display:block">
      
		      <ul>
		        
              
 		          <li>
	              University of Massachusetts - Clinical Pathology
		          </li>
		          
		        
              
 		          <li>
	              Harvard University - Chemical Biology &amp; Chemistry
		          </li>
		          
		        
              
 		          <li>
	              Purdue University - Natural Products &amp; Chemical Synthesis
		          </li>
		          
		        
		      </ul>
		      
		      
		        <div class="showhide-block" id="moreedu">
		          <ul>
		            
                
		            <li>
		              <div name="education">
		              
		                University of Minnesota - Chemistry, Biochemistry &amp; Microbiology
		              
		              </div>
		            </li>
		            
		            
		          </ul>
                <p class="seeall showhide-link"><a href="#" id="moreedu-hide">see less</a></p>
		        </div>
                <p class="seeall showhide-link"><a href="#" id="moreedu-show">see all</a></p>
		      
        
    </dd>
  
  
  
  
    <dt>
       Recommendations
    </dt>
    <dd>
      <p>
        
            
                <strong>9</strong> people have recommended Mark Brian
              
          
      </p>
    </dd>
  

  
  
    
    <dt>
      Connections
    </dt>
    <dd class="overview-connections">
      <p>
      
        <strong>500+</strong>  connections
      
      </p>
    </dd>
    
  

  
  
  
    <dt class="websites">Websites</dt>
    <dd class="websites">
      
	      <ul>
	        
	          
            <li>
              <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Emarkbriananderson%2Ecom&amp;urlhash=5T3V" target="_blank" title="New window will open" name="overviewsite">
              
                Personal Website
                
              </a>
              
            </li>
	        
	      </ul>
	      
    </dd>
  
  
  
    

  
  
  
  
  
    
  
</dl>

<script type="text/javascript">
  showHide.init('overview');
</script>











          

          
          
            
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      












  <div class="section" id="profile-summary" style="display:block">

    <div class="header">
      <h2>
				Mark Brian Anderson, PhD, RAC's Summary
				
				
			</h2>
    </div>

    <div class="content">

      
      
      
        
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description summary">
    Expertise: Contract &amp; Consult<br>
<br>
1 - FDA Regulatory &amp; Clinical Affairs:<br>
&#x2022; Oversight &amp; management of all CRO operational functional departments, Project Management, Data Management, Site Management, Clinical Review, Safety and Medical Management; <br>
&#x2022; Execution of operating strategy;<br>
&#x2022; Work collaboratively with Business Development to develop and defend proposals for new research programs;<br>
&#x2022; Published US FDA Regulatory Affairs Handbook &quot;From Principle to Practice: Bugs, Drugs &amp; Attachments&quot; published &amp; available on Amazon Books;  http://www.fdaregulatoryhandbook.com <br>
&#x2022; Drug - IND/NDA, ANDA<br>
&#x2022; Biologic - IND/BLA<br>
&#x2022; Medical Device - 510(k), IDE/PMA &amp; HUD/HDE(design history to clearance/approval)<br>
&#x2022; Other - IVD, Combination Products, biologic 510(k), generics &amp; OTC <br>
&#x2022; Post Approval &amp; Clearance <br>
&#x2022; International CTA, MAA <br>
&#x2022; Product Development &amp; planning<br>
<br>
2 -Scientific Director &amp; Chief Scientific Officer:<br>
&#x2022; Preclinical &amp; Nonclinical R&amp;D - Clinical pathology, medicinal chemistry, assays, models, innovative technologies, technology transfers, safety, pharmacology (e.g. ADME, TOX, TK, PK, PD), posology, formulations, container closure, etc.  <br>
&#x2022; Clinical Development - Phase 1-3, CMC, Devices, etc. <br>
&#x2022; Product Development - Therapeutic agent based on PMOA, 510(k), combination products, etc. <br>
&#x2022; Strategic Planning &amp; Executive Relations - FDA planning, SABs, BODs, KOLs, M&amp;A, Investors, etc. <br>
&#x2022; Documents - Patent applications, medical writing, scientific writing, presentations, manuscripts, etc.<br>
<br>
3 - Business Development:<br>
&#x2022; US &amp; International partnering &amp; collaborations<br>
&#x2022; Product Development &amp; Planning - Customers, competition &amp; building a competitive advantage<br>
&#x2022; Deal sheet<br>
<br>
4 - Therapeutic Areas:<br>
&#x2022; Infectious disease (bacterial, viral, fungal) <br>
&#x2022; Oncology/MDR <br>
&#x2022; ENT, ophthalmology, dermatology, chronic non-healing wounds, biomarkers/surrogates, urology, and sinusitis<br>
&#x2022; Immunology<br>
&#x2022; Neuroendocrine<br>
&#x2022; Neurodegenerative / neurology disease <br>
&#x2022; Inflammatory, cardiovascular, pulmonary diseases
</p>


    
      
      
	      
	      
    </div>
  </div>









	            
          
            
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


    
  
      
  
      
  
      
  
      
  
      
  
      
  
      
  
      
  
      
  
      

      
      








<div class="section subsection-reorder" id="profile-experience" style="display:block">
  <div class="header">
    <h2>Mark Brian Anderson, PhD, RAC's Experience
	  </h2>
  </div>
  <div class="content vcalendar">
  <div> 
    <div>
    <div class="position  first experience vevent vcard summary-current" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Biotech Pharma Solutions (BPS) Nutrafortified</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Nutrafortified</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details current-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2012-02-01">February 2012</abbr>
  	              &#8211; <abbr class="dtstamp" title="2013-09-23">Present</abbr>
  	          <span class="duration"><span class="value-title" title="P1Y8M"> </span>(1 year 8 months)</span>
                  <span class="location">California</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description current-position">
    &#x2022; Contract consultant for Regulatory Affairs, Clinical Affairs and Business Development<br>
<br>
&#x2022; Confidential consulting with CEOs, owners and growers to develop market plan for natural products,  regulatory affairs &amp; guidance &#x2013; CFSAN (Center for Food Safety and Applied Nutrition), product prototyping, business planning and development.
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-current" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Biotech Pharma Solutions (BPS) Contract Consultant General</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             
                 <a class="company-profile-public" href="/company/biotech-pharma-solutions?trk=ppro_cprof"><span class="org summary">Biotech Pharma Solutions</span></a>
               
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details current-position">
  	        Privately Held; 1-10 employees;
	  	      Pharmaceuticals industry
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2009-03-01">March 2009</abbr>
  	              &#8211; <abbr class="dtstamp" title="2013-09-23">Present</abbr>
  	          <span class="duration"><span class="value-title" title="P4Y7M"> </span>(4 years 7 months)</span>
                  <span class="location">Boston &amp; San Francisco</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description current-position">
    &#x2022; FDA Regulatory &amp; Clinical Affairs:<br>
- Drugs, biologics, medical devices and combination products<br>
- Oversight &amp; management of all CRO operational functional departments, Project Management, Data Management, Site Management, Clinical Review, Safety and Medical Management; <br>
- Execution of operating strategy;<br>
- Work collaboratively with Business Development to develop and defend proposals for new research programs;<br>
<br>
&#x2022; Business Development:<br>
- Partnerships &amp; collaborations<br>
- Market repositioning<br>
- Corporate relationships, product review for M&amp;A, etc.  <br>
<br>
&#x2022; Scientific Director &amp; Consulting Chief Scientific Officer:<br>
- Oversight of research, medicinal chemistry, microbiology, cell biology, biochemistry, analytical chemistry, formulations, pharmaceutical development (API &amp; drug product), pharmacology, DMPK, ADME, safety, TOX, bioanalytical, biomarkers, and disease pathologies<br>
- Medical writing, scientific writing, presentations and invited lectures<br>
- Product development support from discovery to Early-Stage Development (discovery to Phase 2) &amp; Late-Stage Clinical Development (Phase 3 to Phase 4) for agents &amp; devices<br>
- Elucidate new mechanism of action (MOA) of new chemical entities <br>
 <br>
&#x2022; Agents &amp; Materials:<br>
- Small molecule, proteins, peptides, antibodies, natural products, new vaccine research, test kit innovations, microRNA, complex macromolecules (e.g. oligosaccharides), develop new 510(k) opportunities and combination products  <br>
<br>
Call 1-510-219-5188 for an appointment
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-current" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Biotech Pharma Solutions (BPS) MNOW Experts Consult</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">MNOW&#x2122; Experts</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details current-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2012-02-01">February 2012</abbr>
  	              &#8211; <abbr class="dtstamp" title="2013-09-23">Present</abbr>
  	          <span class="duration"><span class="value-title" title="P1Y8M"> </span>(1 year 8 months)</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description current-position">
    MNOW&#x2122; Experts: A LeadPhysician Resource. MED360: A Division of WorldOne. <br>
<br>
MNOW&#x2122; Experts is &#x201c;A LeadPhysician Resource&#x201d; <br>
<br>
Market trends, clinical software, and pharmaceuticals<br>
<br>
Consulting with financial institutions, life sciences foundations, and leading conference organizers. <br>
<br>
Med360 is built exclusively for decision makers as a tool to maximize their global healthcare knowledge to gain timely insights and ground-level analysis on issues affecting pharmaceutical, biotechnology, medical device, and healthcare service sub-sectors around the world.
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Biotech Pharma Solutions (BPS) NovaBay Pharmaceuticals Consult</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             
                 <a class="company-profile-public" href="/company/novabay-pharmaceuticals?trk=ppro_cprof"><span class="org summary">NovaBay Pharmaceuticals</span></a>
               
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        Public Company; 11-50 employees;
	  	      Pharmaceuticals industry
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2012-01-01">January 2012</abbr>
 &#8211; <abbr class="dtend" title="2013-08-01">August 2013</abbr>  	          <span class="duration"><span class="value-title" title="P1Y8M"> </span>(1 year 8 months)</span>
                  <span class="location">San Francisco Bay Area</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    NovaBay Pharmaceuticals, Inc., is a clinical-stage biotechnology company<br>
<br>
Infectious diseases related to ophthalmology, ENT, dermatology, urology and hospital treated wound infections<br>
<br>
NeutroPhase is a FDA cleared 510(k) medical device for use in the irrigation, cleansing and debridement of chronic non-healing wounds<br>
<br>
Auriclosene (NVC-422) is in clinical trials as a topical gel for impetigo<br>
<br>
Auriclosene is in clinical trials as an ophthalmic formulaion for viral conjunctivitis<br>
<br>
Auriclosene the lead Aganocide&#xae; is a broad-spectrum, fast-acting, non-antibiotic antimicrobial agent with a novel mechanism of action (published) and no decrease in susceptibility to auriclosene in multiple passage studies against MRSA, S. aureus, P. aeruginosa and E. coli (published).
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Biotech Pharma Solutions (BPS) Startups &amp; CRO Consult</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Startups, Biotech and Pharma</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2012-03-01">March 2012</abbr>
 &#8211; <abbr class="dtend" title="2013-07-01">July 2013</abbr>  	          <span class="duration"><span class="value-title" title="P1Y5M"> </span>(1 year 5 months)</span>
                  <span class="location">California</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    &#x2022; Oversight &amp; management of all CRO operational functional departments, Project Management, Data Management, Site Management, Clinical Review, Safety and Medical Management;<br>
 <br>
&#x2022; Execution of operating strategy;<br>
<br>
&#x2022; Work collaboratively with Business Development to develop and defend proposals for new research programs;<br>
<br>
&#x2022; Confidential consulting with CEOs, BODs, company owners &amp; CROs<br>
<br>
&#x2022; Study drugs  IND/NDA/ANDA, medical devices 510(k) or IDE/PMA, biologics IND/BLA, combination products focusing jurisdictions based on PMOA, and generic drugs as required<br>
<br>
&#x2022; FDA Regulatory Affairs &amp; Compliance Consulting (RAC certified)<br>
<br>
&#x2022; Program Management (PM), Clinical Development Planning (CDP)<br>
<br>
&#x2022; Nonclinical Pharmacology, Disease Models &amp; TOX<br>
<br>
&#x2022; Business development, Review in-licensed agents<br>
<br>
&#x2022; Medical &amp; Scientific Writing<br>
<br>
&#x2022; Grants - write/edit grant applications
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Biotech Pharma Solutions (BPS) NovaBay Pharmaceuticals Chief Scientific Officer</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             
                 <a class="company-profile-public" href="/company/novabay-pharmaceuticals?trk=ppro_cprof"><span class="org summary">NovaBay Pharmaceuticals</span></a>
               
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        Public Company; 11-50 employees;
	  	      Pharmaceuticals industry
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2009">2009</abbr>
 &#8211; <abbr class="dtend" title="2012-01-01">January 2012</abbr>  	          <span class="duration"><span class="value-title" title="P3Y"> </span>(3 years)</span>
                  <span class="location">Emeryville, California</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    NovaBay is a clinical-stage biotechnology company developing NeutroPhase&#xae; and Auriclosene (NVC-422). <br>
<br>
Infectious diseases related to ophthalmology, dermatology, urology and hospital treated wound infections<br>
<br>
NeutroPhase is a FDA cleared 510(k) medical device for use in the irrigation, cleansing and debridement of chronic non-healing wounds<br>
<br>
Auriclosene (NVC-422) is in clinical trials for impetigo as a dermal gel<br>
<br>
Auriclosene is in clinical trials for vrial conjunctivitis as a ophthalmic solution<br>
<br>
Auriclosene is NovaBay's lead Aganocide&#xae; which is a broad-spectrum, fast-acting, non-antibiotic antimicrobial agent (published) with a new mechanism of action (published) against bacteria, viruses and fungi that does not develop drug resistance (published). Additional publications in ENT and Urology regarding urinary catheter blockage and encrustation (UCBE)<br>
<br>
International &amp; US Alliances with Galderma, AS; Alcon; University of Innsbruck. <br>
<br>
Pharmaceutical drug development, drug discovery, microbiology, cell biology, analytical chemistry, formulations, eCTD, medical writing, patents/applications, alliances, business development presentations, IND/Pre-IND writing/editing<br>
<br>
Grants -  tax grant (funded), SBIR<br>
<br>
Product Development &amp; Product Launch Team Member  &#x2013; 510(k) irrigation solution for infectious disease &amp; chronic non healing wounds. In Clinic - Ophthalmic solutions &amp; ophthalmic hydrogels; topical gel for infectious disease; a topical solution; gel and ointment for veterinary products for infectious diseases; combination products (drug plus device) for urinary catheter blockage and encrustation (UCBE) and CAUTI)
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Vice President at Myriad Genecics/Myriad Pharmaceuticals</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             
                 <a class="company-profile-public" href="/company/myriad-genetics?trk=ppro_cprof"><span class="org summary">Myriad Genetics-Pharmaceuticals</span></a>
               
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        Public Company; 1001-5000 employees; MYGN;
	  	      Biotechnology industry
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2003-12-01">December 2003</abbr>
 &#8211; <abbr class="dtend" title="2009-03-01">March 2009</abbr>  	          <span class="duration"><span class="value-title" title="P5Y4M"> </span>(5 years 4 months)</span>
                  
       
     
                      <span class="location">Greater Salt Lake City Area</span>
                  
       
     
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Vice President of Research; Chemistry: R&amp;D discovery and clinical development teams. <br>
<br>
Myriad Genetics (MYGN) is a molecular diagnostic company based in Salt Lake City, Utah employing proprietary technologies that help doctors and patients understand the genetic basis of human disease onset and progression. <br>
<br>
Myriad pharmaceuticals developed therapies targeting important disease targets.<br>
<br>
Disease targets: Alzheimer&#x2019;s disease (neurodegeneration), cancer (glioblastoma, melanoma, etc), blood coagulation pathways, HIV (novel HIV agents, HIV maturation inhibitors, etc), and other undisclosed targets identified through proprietary methods and/or human genetics. <br>
<br>
Myriad Pharmaceuticals was a wholly owned subsidiary of Myriad Genetics which spun-off July 2009 (Myrexis; MYRX).<br>
<br>
Clinical Development<br>
Azixa (MPC-6827) Non-Small-Cell Lung Cancer Phase 2<br>
Azixa (MPC-6827) Melanoma Phase 2<br>
Azixa (MPC-6827) Glioblastoma Phase 2<br>
Vivecon (MPC-9055) HIV Maturation Phase 1<br>
MPC-2130 Metastatic &amp; Blood Cancers Phase 1<br>
MPC-0920 Thrombosis Phase 1<br>
MPC-3100 for Cancer Phase 1<br>
Flurizan backups (tarenflurbil) for Alzheimer's &amp; patent applications<br>
Pre-CMC, Salt Forms &amp; Formulations<br>
IND writing/editing/reviewing<br>
FDA Type B preparations<br>
<br>
Preclinical R&amp;D<br>
Created a R&amp;D preclinical drug  development strategy with a robust pipeline of IND-Ready agents.<br>
<br>
Direct, lead and manage R&amp;D discovery, <br>
Drive IP opportunity, preclinical drug development profiling/candidate selection, <br>
Shepherd new agents into clinic, R&amp;D to IND, IND to clinical proof of concept (P1/2), <br>
Familiar with WHO/INN/USAN <br>
FDA CDER/CDRH, and disease pathology/translational opportunities. <br>
Business acumens to develop personnel and programs. Developed the drug discovery team from 6 to 40+<br>
Results: multiple agents into the clinic and a robust preclinical drug development pipeline focused on an ROI.  JCRCs, Technology, etc.<br>
<br>
Grants - pending<br>
<br>
Cell +00 1-510-219-5188
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Senior Director at Elitra Pharmaceuticals</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             <span class="org summary">Elitra Pharmaceuticals</span>
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        
	  	      
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="2002-07-01">July 2002</abbr>
 &#8211; <abbr class="dtend" title="2003-11-01">November 2003</abbr>  	          <span class="duration"><span class="value-title" title="P1Y5M"> </span>(1 year 5 months)</span>
                  <span class="location">La Jolla, California</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Elitra Pharmaceuticals (private company) identified more than 6,000 essential genes in eleven (11) bacterial and fungal pathogens. Elitra (RS3/Trius) was acquired by Merck<br>
<br>
Infectious diseases &amp; anti-bioterrorism related to Gram-negative, Gram-positive and fungal pathogens<br>
<br>
&gt;11 Alliances in infectious disease R&amp;D including Merck &amp; Co. (US); LG Life Sciences (Korea); BioLeads (EU); Kaken (Japan); deCODE genetics (Reykjavik, Iceland and US facility); MediChem; and others. <br>
<br>
New screening technology<br>
Identify/confirm molecular targets for known drugs<br>
Identify molecular targets for new drugs<br>
<br>
Lead optimization &amp; Pre-CMC development<br>
Review in-license opportunities CMC &amp; IND<br>
Clinical Development Planning (Phase 1 &amp; 2)<br>
NDA/Marketing planning <br>
Grants - writing/editing, SBIRs (funded), private (funded) <br>
<br>
CDER, CBER, CDRH<br>
WHO/INN/USAN
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Associate Director Medicinal Chemistry at Pfizer-Agouron</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             
                 <a class="company-profile-public" href="/company/pfizer?trk=ppro_cprof"><span class="org summary">Pfizer - Agouron Pharmaceuticals</span></a>
               
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        Public Company; 10,001+ employees; PFE;
	  	      Pharmaceuticals industry
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="1997-09-01">September 1997</abbr>
 &#8211; <abbr class="dtend" title="2002-06-01">June 2002</abbr>  	          <span class="duration"><span class="value-title" title="P4Y10M"> </span>(4 years 10 months)</span>
                  <span class="location">La Jolla, California</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Pfizer merged with Warner-Lambert (Agouron Pharmaceuticals) February 3, 2000 for $87 billion USD. <br>
<br>
Anticancer and antiviral therapeutics R&amp;D<br>
<br>
Neuroendocrine project leader (GnRH) for cancer  (ovarian, breast and prostate)<br>
Structure-based drug design (SBDD) <br>
Target library-based lead optimization<br>
Combinatorial chemistry technologies <br>
IND candidate nomination <br>
CHK-1 &amp; othe SBDD kinases <br>
Pfizer CAN guidelines<br>
Viral targets in human disease <br>
<br>
Recipient of the Agouron Pharmaceuticals President's Award for outstanding contributions in drug discovery research (January 1999)<br>
Manage &amp; mentor large multidepartmental teams<br>
Budgets<br>
Oncology discovery advisory group (ODAG)<br>
Virology development group<br>
New technology development
</p>

  

  	  </div>
			</div>
    <div>
    <div class="position   experience vevent vcard summary-past" style="display:block">
      <a class="include" href="#name"></a>

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
























<div class="postitle">
   <h3 class="false"> 
   
       <span class="title">Senior Research Scientist / International Project Leader</span>  
     
   
   </h3>
   
      <h4><strong>
      
         
             
                 <a class="company-profile-public" href="/company/ligand-pharmaceuticals?trk=ppro_cprof"><span class="org summary">Ligand Pharmaceuticals - Glycomed Incorporated</span></a>
               
           
         
       
      </strong></strong> 
       </h4>
    
</div>











      
       
     
      
 	      <p class="orgstats organization-details past-position">
  	        Public Company; 11-50 employees; LGND;
	  	      Pharmaceuticals industry
  	    </p>
  	    <p class="period">
  	          <abbr class="dtstart" title="1992-04-01">April 1992</abbr>
 &#8211; <abbr class="dtend" title="1997-09-01">September 1997</abbr>  	          <span class="duration"><span class="value-title" title="P5Y6M"> </span>(5 years 6 months)</span>
                  <span class="location">San Diego &amp; Alameda California</span>
  	    </p>
        
       
     

            

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" description past-position">
    Ligand Pharmaceuticals is a cutting-edge drug discovery biotech in La Jolla, California with a keen interest in the drug reformulation segment of the pharmaceutical industry.<br>
<br>
Glycomed Inc. (Alameda, CA) became a subsidiary of San Diego based Ligand Pharmaceuticals Inc. May 18, 1995   <br>
<br>
Oncology/cancer, cell adhesion, inflammatory diseases, pulmonary injury, asthma, cardiac ischemia-reperfusion injury, granulomatous vasculitis, eye disease, infection and aberrant cell adhesion mediated diseases<br>
<br>
Drug discovery (small molecules, hybrids, complex oligosaccharides)<br>
Pre-IND R&amp;D candidate selection<br>
Pre-IND lead scale-ups<br>
Animal disease models<br>
Coordinate Pre-CMC scale-up with clinical development<br>
Manufacturing site inspections<br>
Peptides &amp; peptidomimetics<br>
<br>
Sankyo Co. Ltd, Tokyo, Japan<br>
The Canadian Alberta Research Council (ARC)<br>
Johns Hopkins Asthma and Allergy Center, Baltimore, MD.<br>
University of Michigan Medical School Department of Pathology <br>
University of Michigan Medical School Department of Pharmacology <br>
MD Anderson Cancer Center in Houston Texas<br>
University of Michigan at Kalamazoo
</p>

  

  	  </div>
			</div>
  </div>
   
  </div>
</div>



              
          
            
              
              
              
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      

      
        
      











  


  

  <div class="section" id="profile-certifications" style="display:block">
    <div class="header">
      <h2>Mark Brian Anderson, PhD, RAC's Certifications
        
      </h2>
    </div>
    
    
    <div class="content">
      
      
      
        
        <ul class="certifications documents">
          
            <li class="certification first">
              <h3>
                RAC - Regulatory Affairs Certification
                
              </h3>
              
              
              
       
     
              
              
       
     
            </li>
          
        </ul>
      
    </div>
  
  </div>
  

  








              
              
              
              
              
              
              
              
              
              
          
            
              
              
              
              
              
              
              
              
              
               
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      














  

  <div class="section" id="profile-honorsawards" style="display:block">
    <div class="header">
      <h2> Mark Brian Anderson, PhD, RAC's Honors and Awards
        
      </h2>
    </div>

    <div class="content">
      
      
      
        
        <ul class="honorawards documents">
          
            <li class="honoraward  first">
  
              
              <h3>
                RAC Certified
                
              </h3>
              
       
     
                
                                
                

                
                
                
              
       
     

              
                
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" summary">
    Regulatory Affairs Certification
</p>


    
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    



   



  
  



  




  
    
  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141289-1" type="linkedin/control" class="li-control">
            
      
        
        
        /* extlib: _showmore */
          
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    
LI.i18n.register( 'ShowMore-see-more', 'more' );
LI.i18n.register( 'ShowMore-see-less',   'less' );
LI.i18n.register( 'ShowMore-see-more-long',   'Show more' );
LI.i18n.register( 'ShowMore-see-less-long',   'Show less' );

        
        
        
        
      
    
            LI.Controls.addControl('control-http-12248-9141289-1', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
              


              
            </li>
          
            <li class="honoraward ">
  
              
              <h3>
                Patents, Publicagtions &amp; Presentations
                
              </h3>
              
       
     
                
                                
                

                
                
                
              
       
     

              
                
                  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" summary">
    &gt; 120 Patents &amp; Applications<br>
<br>
&gt; 110 Peer-reviewed manuscripts &amp; presentations
</p>


    
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141290-2" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141290-2', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
              


              
            </li>
          
        </ul>
      
    </div>

  </div>











              
              
              
              
          
            
              
              
              
              
              
               
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      

      
        
      















  <div class="section" id="profile-languages" style="display:block">

    <div class="header">
      <h2>Mark Brian Anderson, PhD, RAC's Languages
        
      </h2>
    </div>

    <div class="content">
      
      
      
        
        <ul class="languages competencies">
          
            <li class="competency language">
              
       
     
              <h3>Spanish, French, German, Swedish</h3>
              
              
       
     
            </li>
          
        </ul>
      
    </div>

  </div>











              
              
              
              
              
              
              
              
          
            
              
              
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      

      
        
      
















  

  <div class="section" id="profile-publications" style="display:block">

    <div class="header">
      <h2>Mark Brian Anderson, PhD, RAC's Publications
        
    </h2>
  </div>

    <div class="content">
      
      
      
        
        <ul class="publications documents">
          
            <li class="publication vevent vcard first">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fs%2Fref%3Dnb_sb_noss%3Furl%3Dsearch-alias%253Daps%26field-keywords%3D9780989887311&amp;urlhash=vyBp" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>From Principle to Practice: Bugs, Drugs &amp; Attachments</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Biotech Pharma Solutions</li><li class="dtstart">August 31, 2013</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://www.linkedin.com/pub/mark-brian-anderson-phd-rac/0/81b/a99">Mark Brian Anderson, PhD, RAC</a>
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    From Principle to Practice: Bugs, Drugs &amp; Attachments. When Time Matters, Where to find it! is a compact easy-to-carry reference handbook on US Regulatory Affairs.<br>
<br>
Navigating the US Regulatory pathways from initial application to the FDA to market approval or clearance is a highly demanding process that is complete with many technical and regulatory challenges that sometimes leaves us exclaiming &#x2018;What the Muffin!&#x2019; <br>
<br>
&#x2018;What the Muffin!&#x2019; is a humorous rendition of what so many people had thought or uttered when presented with unanticipated program challenges; busted timelines; wrong turns; or a Form FDA 483. The phrase &#x2018;What the Muffin!&#x2019; makes us smile and cringe all at the same time. <br>
<br>
&#x2018;Bugs, Drugs and Attachments&#x2019; summarize the many sources of therapeutic agents, medical devices and combination products that we work with on a regular basis. This spirited title was chosen to stir the imagination and result in an opportunity for results-oriented discussion. Working with bugs, drugs and attachments is done in concert with the US FDA, regulatory agencies and our clinical development teams entrusted with our most precious deliverables.<br>
<br>
&#x2018;From Principle to Practice&#x2019; is an encapsulation of the concept of transforming scientific principles and opportunities into clinical practice and marketable products by focusing on key deliverables in a work plan. <br>
<br>
The global biomedical industry and regulatory requirement environment is continuously evolving. We as professionals and industry leaders need to adapt to these evolutions if we want to gain market approvals or clearances for our intended products. <br>
<br>
Use this handbook as a portable reference handbook to stir discussion and highlight where to find the authoritative sources. Identifying the intended use and appropriate regulatory pathway is one of the important keys to success in developing meaningful therapeutic products to market approval or clearance. <br>
<br>
I hope you enjoy it.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141291-3" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141291-3', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fijbt%2Eorg%2F&amp;urlhash=aiVk" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>NeutroPhase&#xae; in chronic non-healing wounds.</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>International Journal of Burns &amp; Trauma</li><li class="dtstart">December 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://www.linkedin.com/pub/mark-brian-anderson-phd-rac/0/81b/a99">Mark Brian Anderson, PhD, RAC</a>, J Crew, R Varilla, T Rocas, D Debabov, L Wang, A Najafi, S Rani, R Najafi
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Chronic non-healing wounds, such as venous stasis ulcers, diabetic ulcers, and pressure ulcers are serious unmet medical needs that affect a patient&#x2019;s morbidity and mortality. Common pathogens observed in chronic non-healing wounds are Staphylococcus including MRSA, Pseudomonas, Enterobacter, Stenotrophomonas, and Serratia spp. Topical and systemically administered antibiotics do not adequately decrease the level of bacteria or the associated biofilm in chronic granulating wounds and the use of sub-lethal concentrations of antibiotics can lead to resistant phenotypes. We show 5 representative examples from our more than 30 clinical case studies using NeutroPhase as an irrigation solution with chronic non-healing wounds with and without the technique of negative pressure wound therapy (NPWT). NeutroPhase&#xae; is pure 0.01% hypochlorous acid (i.e. &gt;97% relative molar distribution of active chlorine species as HOCl) in a 0.9% saline solution at pH 4-5 and is stored in glass containers. NovaBay has three FDA cleared 510(k)s. Patients showed a profound improvement and marked accelerated rates of wound healing using NeutroPhase with and without NPWT. NeutroPhase&#xae; was non-toxic to living tissues.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141291-4" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141291-4', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fonlinelibrary%2Ewiley%2Ecom%2Fdoi%2F10%2E1002%2Falr%2Ev2%2E4%2Fissuetoc&amp;urlhash=J7se" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Efficacy of NVC-422 against Staphylococcus aureus biofilms in a sheep biofilm model of sinusitis.</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>International Forum of Allergy &amp; Rhinology, 2012, 2, 309-315.</li><li class="dtstart">August 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://www.linkedin.com/pub/mark-brian-anderson-phd-rac/0/81b/a99">Mark Brian Anderson, PhD, RAC</a>, &#x2022;	Deepti Singhal Andreas Jekle Dmitri Debabov Lu Wang Bez Khosrovi Mark Anderson  Andrew Foreman and Pe
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Bacterial biofilms are a major obstacle in management of recalcitrant chronic rhinosinusitis. NVC-422 is a potent, fast-acting, broad-spectrum, nonantibiotic, antimicrobial with a new mechanism of action effective against biofilm bacteria in in vitro conditions. The aim of this study was to investigate the safety and efficacy of NVC-422 as local antibiofilm treatment in a sheep model of rhinosinusitis.<br>
(see abstract)
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141291-5" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141291-5', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eijcep%2Ecom%2FV4_No6%2Ehtml&amp;urlhash=Uol_" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>NVC-422 Topical Gel for the Treatment of Impetigo.</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>International Journal of Clinical and Experimental Pathology. 2011; 4(6):587-595.</li><li class="dtstart">August 2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://www.linkedin.com/pub/mark-brian-anderson-phd-rac/0/81b/a99">Mark Brian Anderson, PhD, RAC</a>, &#x2022;	Susan M. Iovino Kenneth D. Krantz  Daisy M. Blanco Josefina A. Fern&#xe1;ndez Naomi Ocampo Azar Najafi Bahr
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Impetigo is a highly contagious bacterial skin infection affecting children worldwide that is caused by the Gram-positive bacteria Staphylococcus aureus, Streptococcus pyogenes, or both. Staphylococcus species can quickly develop drug resistance rendering mupirocin, fusidic acid, and erythromycin ineffective. Preclinical and clinical studies demonstrated that NVC-422 (N,N-dichloro-2,2 dimethyltaurine) rapidly kills pathogens without the development of drug resistance. (c.f. publication)
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141292-6" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141292-6', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Faac%2Easm%2Eorg%2Fcontent%2Fearly%2Frecent&amp;urlhash=-Qq_" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>NVC-422 Inactivates Staphylococcus aureus Toxins.</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Antimicrob. Agents Chemother. published ahead of print 3 December 2012 , doi:10.1128/AAC.01945-12.</li><li class="dtstart">December 3, 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://www.linkedin.com/pub/mark-brian-anderson-phd-rac/0/81b/a99">Mark Brian Anderson, PhD, RAC</a>, A Jekle, J Yoon, M Zuck, R Najafi, L Wang, T Shiau, C Francavilla, S Rani, C Eitzinger, M Nagl, and D Debabov
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Bacterial pathogens have specific virulence factors (e.g. toxins) that contribute significantly to the virulence and infectivity of microorganisms within the human hosts. Virulence factors are molecules expressed by pathogens that enable colonization, immunoevasion, immunosuppression, obtaining nutrients from the host or gaining entry into host cells. For example, in systemic Staphylococcus aureus infections virulence factors such as Toxic Shock Syndrome Toxin 1 (TSST-1), Staphylococcal Enterotoxin A (SEA) and Staphylococcal Enterotoxin B (SEB) cause sepsis or toxic shock by uncontrolled stimulation of T-lymphocytes and by triggering a cytokine storm. In vitro, these superantigens stimulate the proliferation of human peripheral blood mononuclear cells (PBMC) and the release of many cytokines. Using mass-spectrometry, we demonstrate here that NVC-422 oxidizes methionine residues of TSST-1, SEA, SEB and Exfoliative Toxin A (ETA). These results show that, in addition to its well-described direct microbicidal activity, NVC-422 can inactivate S. aureus virulence factors through rapid oxidation of methionines. 
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141292-7" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141292-7', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Encbi%2Enlm%2Enih%2Egov%2Fpubmed%2F22024427&amp;urlhash=upt3" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis.</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Antiviral Res. 2011, 92(3), 470-8</li><li class="dtstart">December 2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://www.linkedin.com/pub/mark-brian-anderson-phd-rac/0/81b/a99">Mark Brian Anderson, PhD, RAC</a>, Yoon J, Jekle A, Najafi R, Ruado F, Zuck M, Khosrovi B, Memarzadeh B, Debabov D, Wang L, Anderson M.
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Human adenoviral conjunctivitis is a highly contagious eye infection affecting millions of people world-wide. If untreated, it can further develop into keratitis, corneal ulceration, scarring and possible blindness. Despite the significant patient morbidity and socio-economic costs, it is an unmet medical need with no FDA approved treatment. Here, we demonstrate the virucidal activity of NVC-422 (N,N-dichloro-2,2-dimethyltaurine) against adenovirus type 5 (Ad5) and investigated its mechanism of action of Ad5 inactivation. (c.f. publication)
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141293-8" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141293-8', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eprous%2Ecom%2F&amp;urlhash=yQLI" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>NVC-422: Drugs of the Future</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Drugs of the Future 2011, 36(9): 651-656.</li><li class="dtstart">2011</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://www.linkedin.com/pub/mark-brian-anderson-phd-rac/0/81b/a99">Mark Brian Anderson, PhD, RAC</a>, Darouiche, D; Najafi, R; Krantz, K; Debabov, D; Friedman, L; Khosrovi, B; Wang, L; Iovino, S; Anderson, M
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    Developing various nonsystemic formulations of this active agent for use in multiple phase II clinical trials for various indications, including urinary catheter blockage and encrustation (UCBE), conjunctivitis and impetigo. Preclinical and clinical studies demonstrated that NVC-422 has a good safety profile and solution stability. NVC-422 is cidal to pathogens by the oxidative modification of sulfur-containing amino acids, such as methionine and cysteine, resulting in protein inactivation. Pathogens die within minutes after exposure to lethal concentrations of NVC-422, as measured by time-kill assays. Multiple passage studies against pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA), show no drug resistance. Its mechanism of action, fast time-kill and no observation of drug resistance uniquely differentiate NVC-422 from traditional antibiotics. (c.f. publication)
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141293-9" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141293-9', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Eingentaconnect%2Ecom%2Fcontent%2Fben%2Fcbc%2F2009%2F00000005%2F00000001&amp;urlhash=zgvl" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Anticancer Agents: VTA or VDA.</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Current Bioactive Compounds, 2009, 5(1), 79-97.</li><li class="dtstart">2009</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://www.linkedin.com/pub/mark-brian-anderson-phd-rac/0/81b/a99">Mark Brian Anderson, PhD, RAC</a>, &#x2022;	Paul R. Sebahar J. Adam Willardsen and Mark B. Anderson.
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    The tumor vasculature is quite an attractive target for anti-cancer/anti-tumor therapy because the blood vessels provide the route for nutrient/waste and oxygen/carbon dioxide exchanges as well as a convenient route for tumor metastatic spread. The complex interplay of the tumor with the local blood vasculature is intriguing. Targeting the vasculature in an effort to control the tumor life cycle is therefore very complex yet enticing as a treatment option. In reviewing the literature discussing vascular targeting/disrupting agents, it is sometimes less than clear as to what exactly defines or differentiates a vascular targeting agent (VTA; antiangiogenic or stopping tumors from producing new blood vessels) from a vascular disrupting agent (VDA; disrupting the &quot;established&quot; tumor vasculature). (c.f. publication)
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141293-10" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141293-10', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fpubs%2Eacs%2Eorg%2Ftoc%2Fjmcmar%2F52%2F8&amp;urlhash=MjJu" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>Discovery of N-(4-Methoxyphenyl)-N,2-Dimethylquinazolin-4-Amine, A Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration.</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>J. Med. Chem., 2009, 52 (8), 2341-2351.</li><li class="dtstart">2009</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://www.linkedin.com/pub/mark-brian-anderson-phd-rac/0/81b/a99">Mark Brian Anderson, PhD, RAC</a>, N Sirisoma, A Pervin, H Zhang, S Jiang, A Willardsen, G Mather, Pleiman, S Kasibhatla, B Tseng, J Drewe, S Cai
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    As a continuation of our structure&#x2212;activity relationship (SAR) studies on 4-anilinoquinazolines as potent apoptosis inducers and to identify anticancer development candidates, we explored the replacement of the 2-Cl group in our lead compound 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (6b, EP128265, MPI-0441138) by other functional groups. This SAR study and lead optimization resulted in the identification of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine (6h, EP128495, MPC-6827) as an anticancer clinical candidate. 
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141294-11" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141294-11', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
            <li class="publication vevent vcard">
              <h3>
                
                    <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Encbi%2Enlm%2Enih%2Egov%2Fpubmed%2F22971221&amp;urlhash=miuZ" target="_blank" title="New window will open" name="publicationsite" class="url"> 
                      <cite>N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models.</cite>
                    </a>
                  
                
              </h3>
              
       
     
              
              
                <ul class="specifics">
                  <li>Acta Ophthalmologica. doi: 10.1111/j.1755-3768.2012.02501.x PMID: 22971221</li><li class="dtstart">September 12, 2012</li>
                </ul>
              
              
              
                <div class="attribution"> Authors: 
                  
                    <a href="http://www.linkedin.com/pub/mark-brian-anderson-phd-rac/0/81b/a99">Mark Brian Anderson, PhD, RAC</a>, Teuchner B, Eitzinger C, Lutz M, Hager T, Schmid E, Bechrakis NE, Zuck M, Jekle A, Debabov D, Nagl M.
                  
                </div>
                
              
       
     
              
              
                <div class="summary">
                    
                      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    N-chlorotaurine (NCT) and its analogues N-monochloro-2,2-dimethyltaurine (NVC-612) and N-dichloro-2,2-dimethyltaurine (NVC-422) are new anti-infectives for topical treatment for conjunctivitis. The aim of this study was to show that these compounds are safe in an EpiOcular model and effective in corneas infected ex vivo. Bacterial accumulations were detected histologically both on the corneal surface and also in the anterior third of the stroma of incised corneal buttons. All three test compounds at a concentration of 55 mm (equals 1% NCT) reduced the bacterial counts of P. aeruginosa and S. aureus by approximately 5 log10 after 60- and 120-min incubation, respectively. Significant killing was observed as early as after 5-min incubation. Also intrastromal bacteria were inactivated. In the EpiOcular&#x2122; tissue model, NCT, NVC-422 and NVC-612 had no or very low potential to irritate corneal tissue. Conclusion:&#x2002; N-chlorotaurine, NVC-422 and NVC-612 are non-irritating in cornea and kill P. aeruginosa and S. aureus, even following penetration into the deeper corneal stromal layers.
</p>


    
                    
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141294-12" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141294-12', 'ShowMore', { charCount:400 });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
                </div>
              
            </li>
          
        </ul>
      
    </div>

  </div>











              
              
              
              
              
              
              
              
              
              
              
          
            
              
              
              
              
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      























  <div class="section" id="profile-skills" style="display:block">

    <div class="header">
      <h2>Mark Brian Anderson, PhD, RAC's Skills &amp; Expertise
        
        
      </h2>
    </div>

    <div class="content">
      
      
      

        
            
            
            <ol class="skills" id="skills-list">
                        
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Clinical+Pathology?proficiency=">
                        
                          Clinical Pathology
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Drug+Discovery?proficiency=">
                        
                          Drug Discovery
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Formulations%2FConsulting?proficiency=">
                        
                          Formulations/Consulting
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Business+Development?proficiency=">
                        
                          Business Development
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Strategic+Consulting?proficiency=">
                        
                          Strategic Consulting
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Clinical+Development?proficiency=">
                        
                          Clinical Development
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Medical+Devices?proficiency=">
                        
                          Medical Devices
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Biologics?proficiency=">
                        
                          Biologics
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Drug+Development?proficiency=">
                        
                          Drug Development
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Lifesciences?proficiency=">
                        
                          Lifesciences
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Biotechnology?proficiency=">
                        
                          Biotechnology
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Regulatory+Affairs?proficiency=">
                        
                          Regulatory Affairs
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Oncology?proficiency=">
                        
                          Oncology
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Infectious+Diseases?proficiency=">
                        
                          Infectious Diseases
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Commercialization?proficiency=">
                        
                          Commercialization
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Regulatory+Strategy+Development?proficiency=">
                        
                          Regulatory Strategy Development
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/RAPS?proficiency=">
                        
                          RAPS
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Immunology?proficiency=">
                        
                          Immunology
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Cardiology?proficiency=">
                        
                          Cardiology
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  ">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Pharmacology?proficiency=">
                        
                          Pharmacology
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/CRO?proficiency=">
                        
                          CRO
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Pharmaceutical+Industry?proficiency=">
                        
                          Pharmaceutical Industry
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Clinical+Trials?proficiency=">
                        
                          Clinical Trials
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/FDA?proficiency=">
                        
                          FDA
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Therapeutic+Areas?proficiency=">
                        
                          Therapeutic Areas
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Medical+Writing?proficiency=">
                        
                          Medical Writing
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Genetics?proficiency=">
                        
                          Genetics
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Biomarkers?proficiency=">
                        
                          Biomarkers
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Clinical+Research?proficiency=">
                        
                          Clinical Research
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Biochemistry?proficiency=">
                        
                          Biochemistry
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Medicinal+Chemistry?proficiency=">
                        
                          Medicinal Chemistry
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Cancer?proficiency=">
                        
                          Cancer
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/R%26D?proficiency=">
                        
                          R&amp;D
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/IND?proficiency=">
                        
                          IND
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Cell+Biology?proficiency=">
                        
                          Cell Biology
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Regulatory+Submissions?proficiency=">
                        
                          Regulatory Submissions
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Neurology?proficiency=">
                        
                          Neurology
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Biopharmaceuticals?proficiency=">
                        
                          Biopharmaceuticals
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Cell?proficiency=">
                        
                          Cell
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Pharmaceutics?proficiency=">
                        
                          Pharmaceutics
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Technology+Transfer?proficiency=">
                        
                          Technology Transfer
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Protein+Chemistry?proficiency=">
                        
                          Protein Chemistry
                        
                      </span>
                    
                  </li>
                
                
       
     
                          
              
       
     
              
                  <li class="competency show-bean  extra-skill">
                     
                    
                      
                      
                        
                      
                    
                      

                      <span class="miniprofile-container jellybean http://www.linkedin.com/skills/api/v1/miniskill/Science?proficiency=">
                        
                          Science
                        
                      </span>
                    
                  </li>
                
                
       
     
              
            </ol>
          
       
        
          
            
              <p class="see-more-less">
                <a href="#">
                  <span class="more-text">View All (43) Skills</span>
                  <span class="less-text">View Fewer Skills</span>
                </a>
              </p>
            
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141300-13" type="linkedin/control" class="li-control">
            
      
        
        
        /* extlib: _toggleclass */
          
        
        
        
        
      
    
            LI.Controls.addControl('control-http-12248-9141300-13', 'ToggleClass', { classname: 'view-all-skills', on: '#profile-skills' });
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
          
        
        
      
    </div>

  </div>














              
              
              
              
              
              
              
              
              
          
            
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


    
  
      
  
      
  
      
  
      
  
      
  
      
  
      
  
      

      
      






  <div class="section subsection-reorder summary-education" id="profile-education" style="display:block">
    <div class="header">
      <h2>
        Mark Brian Anderson, PhD, RAC's Education
      </h2>
    </div>
    <div class="content vcalendar">
			  <div> 
            <div class="position  first education vevent vcard" id="37371473">


                <h3 class="summary fn org">
                  
University of Massachusetts - Clinical Pathology                  
                </h3>


              <h4 class="details-education">
                
                <span class="degree">Certification</span>, 
                  <span class="major">
Clinical Pathology                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="2009-01-01">2009</abbr> &#8211; <abbr class="dtend" title="2010-12-31">2010</abbr>
                    
                  </p>
              
       
     



                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    Mark Anderson, PhD certification in clinical pathology completed 2010 from the Clinical Laboratory and Nutritional Sciences Department, the University of Massachusetts.<br>
<br>
Clinical Pathology studies the causes, nature and effects of clinically relevant diseases elucidating the etiology, pathogenesis, morphology and clinical significance.<br>
<br>
Core: Human Development and Pathophysiology; Advanced Pathophysiology; Health Data Analysis/Statistics; and Infectious Diseases. <br>
<br>
Clinical pathology combines the theoretical and technical knowledge of human anatomy and physiology, clinical chemistry, genetics, immunology, microbiology, hematology, histocompatibility, cellular pathology and other fields as they pertain to the diagnosis, monitoring and prevention of disease.
</p>

    

                  <p class="desc details-education" name="activities"><em>Activities and Societies:</em>
AMP - Association for Molecular Pathology
ASIP - American Society for Investigative Pathology                  </p>





            </div>
            <div class="position  education vevent vcard" id="3447220">


                <h3 class="summary fn org">
                  
Harvard University - Chemical Biology &amp; Chemistry                  
                </h3>


              <h4 class="details-education">
                
                <span class="degree">Postdoctoral Fellow</span>, 
                  <span class="major">
Natural Products &amp; Marine toxins                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="1989-01-01">1989</abbr> &#8211; <abbr class="dtend" title="1992-12-31">1992</abbr>
                    
                  </p>
              
       
     



                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    Mark Anderson, PhD, NSF Postdoctoral Research Fellow - Officer.<br>
<br>
Mentor: Professor Yoshito Kishi, Ph.D. <br>
<br>
Department of Chemistry and Chemical Biology: Palytoxin (PTX) is a complex marine natural product with 71 asymmetric centers isolated from soft coral and is considered to be one of the most toxic non-peptide substances known second to maitotoxin. Palytoxin targets the sodium-potassium pump protein via binding and &#x201c;locking&#x201d; it in a position allowing passive transport of both the sodium and potassium ions, thereby destroying the ion gradient that is essential for most cells. <br>
<br>
Accomplishments: Synthesis and purifications of the synthetic bioisostere incorporated PTX from the palytoxin carboxylic acid (PTC) derived from the selective hydrolysis of the vinylogous urea portion of PTX. Specially trained in the handling of PTX and PTC. Analog testing done at the Harvard University Medical School.
</p>

    

                  <p class="desc details-education" name="activities"><em>Activities and Societies:</em>
Boston Harvard Club Member
San Francisco Harvard Club Member                  </p>





            </div>
            <div class="position  education vevent vcard" id="3819927">


                <h3 class="summary fn org">
                  
Purdue University - Natural Products &amp; Chemical Synthesis                  
                </h3>


              <h4 class="details-education">
                
                <span class="degree">PhD</span>, 
                  <span class="major">
Natural Product Chemistry &amp; Synthesis                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="1984-01-01">1984</abbr> &#8211; <abbr class="dtend" title="1989-12-31">1989</abbr>
                    
                  </p>
              
       
     



                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    Mark Anderson, Doctorate (PhD), NSF and NIH Graduate Research Associate <br>
<br>
Mentor: Professor Phil. L. Fuchs, Ph.D.<br>
<br>
Ph.D. Thesis: &#x201c;New Methodologies Directed towards the Total Synthesis of Cytochalasins C &amp; D.&#x201d; <br>
<br>
Background: The Cytochalasins can be used as &#x201c;molecular tools&#x201d; to better understand actin polymerization, cell motility, ruffling, cell division, contraction, cell stiffness, cytoskeletal movement and other biological processes. <br>
<br>
Constructed advanced intermediates and novel building blocks. Developed a unique Diels-Alder reaction, a novel intramolecular chiral acyl transfer strategy, expanded vinyl sulfone technologies, new cyclopentenylation methodology, anhydrous cerium (III) chloride methodologies, allylsilanes, &#x201c;BEST&#x201d; reagents, silicon and tin reagents and more.
</p>

    






            </div>
            <div class="position  education vevent vcard" id="3819967">


                <h3 class="summary fn org">
                  
University of Minnesota - Chemistry, Biochemistry &amp; Microbiology                  
                </h3>


              <h4 class="details-education">
                
                <span class="degree">BS</span>, 
                  <span class="major">
Chemistry, biochemistry, microbiology                  </span>
                
              </h4>

              
       
     
                  <p class="period">
                    <abbr class="dtstart" title="1979-01-01">1979</abbr> &#8211; <abbr class="dtend" title="1984-12-31">1984</abbr>
                    
                  </p>
              
       
     



                   

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" desc details-education">
    Mark Anderson, B.S. in Chemistry with Biochemistry and Microbiology. <br>
<br>
U of MN: Chemistry, Biochemistry and Microbiology. Conducted numerous undergraduate research studies in the biogenesis of alkaloids, the biology of plant natural product syntheses, and secondary plant metabolites with the late Professor Edward Leete (08Feb1992). <br>
<br>
Niacin (vitamin B3 or nicotinic acid), is a vitamin that prevents the deficiency disease pellagra. However the tetrahydronicotinic acids are also proposed as intermediates in the biosynthesis of secondary plant metabolites and alkaloids. <br>
<br>
Thesis: &#x201c;Studies Directed Toward The Synthesis of 1,2,3,6 Tetrahydronicotinic Acid and Retronecine for Their Use In Plant Biomimetic Syntheses&#x201d;.<br>
<br>
Second Thesis: Electrode surface modifications with chemically modified riboflavins for studying the biology and reduction potential of important enzymes with Professor M. T. Stankovich.
</p>

    






            </div>
        </div>
			   
    </div>
  </div>


              
          
            
              
              
              
              
              
              
              
              
              
              
              
              
          
            
                

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


    
  
      
  
      
  
      
  
      
  
      
  
      
  
      

      
      








  <div class="section" id="profile-additional" style="display:block">
  <div class="header">
    <h2>Mark Brian Anderson, PhD, RAC's Additional Information
    </h2>
  </div>
  <div class="content">
  <dl>
    <dt class="websites" style="display:block">Websites:</dt>
    <dd class="websites" style="display:block">
       <ul>
           <li class="website">
            <a href="/redir/redirect?url=http%3A%2F%2Fwww%2Emarkbriananderson%2Ecom&amp;urlhash=5T3V" target="_blank" title="New window will open" >
               Personal Website
            </a>
           </li>
       </ul>
           </dd>



   <dt class="interests" style="display:block">Interests:</dt>
   <dd class="interests" id="interests" style="display:block">
          <p class="">
Clinical Pathology | Drugs | Biologics |  Medical Devices | microRNA | Monoclonal Antibodies | Genetics | Epigenetics | Pharmaceutical R&amp;D | Pharmacology | Translational Medicine | Toxicology | Dermatology | Ophthalmology | Urology | Wounds | Proteomics | Business Ventures | Medicinal Chemistry | Metabolomics 

Languages          </p>
   </dd>

    <dt class="pubgroups" style="display:block">Groups and Associations:</dt>
    <dd class="pubgroups" id="pubgroups" style="display:block">
              <p class="null">
RAPS - Regulatory Affairs Professionals Society
AMP - Association for Molecular Pathology
ASM - American Society for Microbiology
IDSA - Infectious Diseases Society of America
New York Academy of Sciences, 
ACS - American Chemical Society, 
LinkedIn Groups, etc.              </p>

      <ul class="groups">
      </ul>
    </dd>


    <dt class="honors" style="display:block">Honors and Awards:</dt>
    <dd class="honors" class="last" style="display:block">
          

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    







<p class=" ''">
    2011 - R&amp;D Directions; Notable People in R&amp;D. Article of one of nine people recognized in the February issue of &quot;R&amp;D Directions&quot; for the top noteworthy 2010 leaders who have made lasting contributions in research;  Notable People in R&amp;D, page 16 2011<br>
<br>
Cambridge Who's Who 2009 | Strathmore's Who&#x2019;s Who in Leadership and Achievement 2003 | Who's Who of Executives and Professionals 2003<br>
<br>
Agouron Pharmaceuticals President&#x2019;s Award in drug discovery, January 1999
</p>

    
    </dd>
  </dl>
</div>
</div>

              
          
            
              
              
              
              
              
              
              
              
              
              
              
              
          
            
                
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
	
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      
  
      
      

      
        
      
















<div class="section" id="profile-contact" style="display:block">
  <div class="header">
    
      <h2>Contact Mark Brian for:
        
      </h2>
    
	</div>
  <div class="content">
    
        
        
            
          

        
        
        
        <div class="interested">
          <ul>
              <li>career opportunities</li>
              <li>consulting offers</li>
              <li>new ventures</li>
              <li>job inquiries</li>
              <li>expertise requests</li>
              <li>business deals</li>
              <li>reference requests</li>
              <li>getting back in touch</li>
          </ul>
        </div>
        

        
        
      
  </div>
</div>










              
          
            
              
              
              
              
              
              
              
              
              
              
              
              
          
          

          
            <div class="section view-full-profile">
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      


<div class="header">
  
    <h3>View Mark Brian Anderson, PhD, RAC&#8217;s full profile to...</h3>
  
</div>
<div class="content">
  <ul>
    <li>See who you and <strong>Mark Brian Anderson, PhD, RAC</strong> know in common</li>
    <li>Get introduced to <strong>Mark Brian Anderson, PhD, RAC</strong></li>
    <li>Contact <strong>Mark Brian Anderson, PhD, RAC</strong> directly</li>
  </ul>
  <p class="btn">
    
        <a class="action btn-action" href="https://www.linkedin.com/reg/join-pprofile?_ed=0_dHB8G4tKSI1eNkyEd3uBk2dzQE2AkVU1r9kHbXjxPZGWJlD5Jt4ZMf87SacJnJbVz3FvboiOjm93-w4_iUXBUaaUVPpLbhTl6Xdvdx-wj3u&amp;trk=ppro_viewmore" rel="nofollow"><span>View Full Profile</span></a>
      
  </p>
  
</div>


            </div>
          

        </div>
        


        <div id="extra">
          
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

    
  
      
  
      
  
      
  
      

      
      







          
                
            

          
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      


      
    
  
      
      

      
        
      





<div class="leo-module mod-action name-search">
  <div class="header"><h3>Name Search:</h3></div>
  <div class="content">
    <p><strong>Search for people you know</strong> from over 225 million professionals already on LinkedIn.</p>
    <form name="searchForm" action="/pub/dir/" method="get">
      <ul>
        
        <li>
        
          <label for="first">First Name</label>
        
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141302-14" type="linkedin/control" class="li-control">
            
      
        
        
        /* extlib: _ghostlabel */
          
        
        
        
        
      
    
            LI.Controls.addControl('control-http-12248-9141302-14', 'GhostLabel', {});
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
        <input type="text" name="first" id="first" />
        </li>
        
          <li>
          
            <label for="last">Last Name</label>
          
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    










  


      
      
      
      
      
      
        
        
          <script id="control-http-12248-9141302-15" type="linkedin/control" class="li-control">
            
      
    
            LI.Controls.addControl('control-http-12248-9141302-15', 'GhostLabel', {});
          </script>
        
        
          
        
          
        
        
      
      
      
      
      
      
    
          <input type="text" name="last" id="last" />
          </li>
        
      </ul>
      <p class="action"><input class="search-go" type="submit" name="search" value="Search"/></p>
      <p class="note"> Example: 
        <strong>
        <a href="http://www.linkedin.com/in/jeffweiner08" tracking="ppro_find_others_rh">Jeff Weiner</a>
        </strong>
      </p>
    </form>
  </div>
</div>






          <div class="modules panel">
          
              

      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      
 
      
        
      
  




<div class="leo-module mod-util browsemap">
  <div class="header">
    <h3><strong>Viewers of this profile also viewed...</strong></h3>
  </div>

  <div class="content">
    <ul>
   
      
        
         
           
            
             
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/pub/david-w-anderson/26/583/29b?trk=pub-pbmap">
          
              
          
            
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/3/000/084/0e6/2e19767.jpg" id="img-defer-id-1-41303" class="img-defer-hidden img-defer photo" width="40" height="40" alt="David W. Anderson">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/pub/david-w-anderson/26/583/29b?trk=pub-pbmap">David W. Anderson</a>
        
        </strong><br>
        <span class="headline">Successful Senior Executive in Drug...</span>
      </li>
    


             
            
           
             
        
      
        
         
           
            
             
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/pub/ron-najafi-ph-d/3/1b0/261?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/6/000/25d/18d/0ab3754.jpg" id="img-defer-id-2-41303" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Ron Najafi, Ph.D.">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/pub/ron-najafi-ph-d/3/1b0/261?trk=pub-pbmap">Ron Najafi, Ph.D.</a>
        
        </strong><br>
        <span class="headline">CEO at NovaBay Pharmaceuticals, Inc....</span>
      </li>
    


             
            
           
             
        
      
        
         
           
            
             
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/pub/ashok-bajji/27/79/715?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/1/000/0fa/021/3c05919.jpg" id="img-defer-id-3-41303" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Ashok Bajji">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/pub/ashok-bajji/27/79/715?trk=pub-pbmap">Ashok Bajji</a>
        
        </strong><br>
        <span class="headline">Founder &amp; Chief Scientific Officer at...</span>
      </li>
    


             
            
           
             
        
      
        
         
           
            
             
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/pub/bindya-gadhia-pathak-ms/1a/2a9/96?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/2/000/1f8/355/2a023a4.jpg" id="img-defer-id-4-41303" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Bindya Gadhia Pathak MS">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/pub/bindya-gadhia-pathak-ms/1a/2a9/96?trk=pub-pbmap">Bindya Gadhia Pathak MS</a>
        
        </strong><br>
        <span class="headline">Regulatory Affairs Associate II at...</span>
      </li>
    


             
            
           
             
        
      
        
         
           
            
             
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/pub/mark-anderson/1/783/a17?trk=pub-pbmap">
          
              <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/icon/icon_no_photo_40x40.png" class="photo" height="40" width="40" alt="Mark Anderson">
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/pub/mark-anderson/1/783/a17?trk=pub-pbmap">Mark Anderson</a>
        
        </strong><br>
        <span class="headline"></span>
      </li>
    


             
            
           
             
        
      
        
         
           
            
             
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/in/lawrencegreenfield?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/3/000/0dd/1b8/3485d6e.jpg" id="img-defer-id-5-41303" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Lawrence Greenfield,M.D., Ph.D.">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/in/lawrencegreenfield?trk=pub-pbmap">Lawrence Greenfield,M.D., Ph.D.</a>
        
        </strong><br>
        <span class="headline">Senior Director at Affymetrix</span>
      </li>
    


             
            
           
             
        
      
        
         
           
            
             
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/in/klyush?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/4/000/131/21f/3009e68.jpg" id="img-defer-id-6-41304" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Vadim Klyushnichenko, Ph.D. PMP.">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/in/klyush?trk=pub-pbmap">Vadim Klyushnichenko, Ph.D. PMP.</a>
        
        </strong><br>
        <span class="headline"></span>
      </li>
    


             
            
           
             
        
      
        
         
           
            
             
              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/pub/bassam-damaj-ph-d/5/639/124?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/4/000/170/208/29ba44c.jpg" id="img-defer-id-7-41304" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Bassam Damaj, Ph.D">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/pub/bassam-damaj-ph-d/5/639/124?trk=pub-pbmap">Bassam Damaj, Ph.D</a>
        
        </strong><br>
        <span class="headline">President &amp; CEO Innovus Pharma (INNV)</span>
      </li>
    


             
            
           
             
        
      
        
         
           
            
             
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/in/phumphri?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/1/000/030/0a3/1cdd114.jpg" id="img-defer-id-8-41304" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Paul Humphries">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/in/phumphri?trk=pub-pbmap">Paul Humphries</a>
        
        </strong><br>
        <span class="headline">Head of Chemistry at Reset Therapeutics</span>
      </li>
    


             
            
           
             
        
      
        
         
           
            
             
             
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      






  
      <li class="with-photo">
        
          <a href="http://www.linkedin.com/in/richardmthorn?trk=pub-pbmap">
          
              
          
          
            
                <img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/1/000/06b/269/264b650.jpg" id="img-defer-id-9-41304" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Richard Thorn">
                
              
      
            
          </a>
        
        <strong>
        
            <a href="http://www.linkedin.com/in/richardmthorn?trk=pub-pbmap">Richard Thorn</a>
        
        </strong><br>
        <span class="headline">Program Director at Navidea...</span>
      </li>
    


             
            
           
             
        
      
     
    </ul>
  </div>
 </div>



              
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      


   

            
          </div>
          <div class="ad-block">
              <script type="text/javascript">var dbl_page = 'public_profile';</script>
    	      
              
      
      
      <script type="text/javascript">
      /* <![CDATA[ */
      
        var dbl_src = "http://ad.doubleclick.net/adj/linkedin.dart/" + dbl_page + ";lang=en;tile=1;dcopt=ist;sz=300x250;;" + encodeURIComponent('uprofile=2031957;company=429522;pcntry=us') + ";s=0;ord=" + Math.random() * 10000000000000000 +"?";
        document.write('<sc' + 'ript src="' + dbl_src + '" type="text/javascript"><\/scr' + 'ipt>');
      /* ]]> */
        </script>
      
      
    

            
          </div>
          
            
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      
  
      
      

      
        
      



  


          
        </div>

  
     
      
    
    
  
    
      
        
      
    
    
  
      
      
      
        
      
    
      
        
          
        
        
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 </div>
</div>
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<script type="text/javascript">LI.Controls.processQueue();</script>
        
      
      
      
        
      
    
    
  

  
      
      
      
        
      
    
      
    
      
        
      
    
    
      
     
      
        
      
    
     
      
        
          
        

        
          

          
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


 
 
 

 
 




 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



<div id="footer">
 <div class="wrapper">
 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    

      
    
  
      
      

      
        
      





<div id="directory" class="us">
  <h3>
    
    
        LinkedIn member directory - Browse members <a href="/static?key=country_listing">by country</a>
      
    
  </h3>
  <ol type="a" class="primary">
    
      
        <li>
          <a href="/directory/people-a">a</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-b">b</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-c">c</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-d">d</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-e">e</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-f">f</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-g">g</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-h">h</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-i">i</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-j">j</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-k">k</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-l">l</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-m">m</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-n">n</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-o">o</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-p">p</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-q">q</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-r">r</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-s">s</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-t">t</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-u">u</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-v">v</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-w">w</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-x">x</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-y">y</a>
        </li>
      
    
      
        <li>
          <a href="/directory/people-z">z</a>
        </li>
      
    
    
      <li>
        
            
            <a href="/directory/people-1" class="callout-trigger nlcl-hovercard-trigger">more</a>
        
      </li>
    
    
  </ol>
    
  </div>

 <p id="terms-of-use">
 By using this site, you agree to LinkedIn's <a rel="nofollow" href="/static?key=user_agreement&trk=ftr_useragre">terms of use</a>. Commercial use of this site without express authorization is prohibited.
 </p>
 <p id="copyright">LinkedIn Corporation &copy; 2013</p>
 <ul id="nav-legal">
 <li><a href="/static?key=user_agreement&amp;trk=hb_ft_userag">User Agreement</a></li>
 <li><a href="/static?key=privacy_policy&amp;trk=hb_ft_priv">Privacy Policy</a></li>
 <li><a href="/legal/cookie-policy">Cookie Policy</a></li>
 <li class="last"><a href="/static?key=copyright_policy&amp;trk=hb_ft_copy">Copyright Policy</a></li>
 </ul>
 </div>
 </div>


      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      


  
     
      
    
    
    
    
    
    
    
    
    
  
    
      
        
          
            
                
              
          
        
      
    
    
  <script type="text/javascript">
    LI.define("RUM.urls");
    LI.define("RUM.flags");
    LI.RUM.flags['host-flag'] = "control";
    LI.RUM.urls['rum-track'] = "/lite/rum-track?csrfToken=ajax%3A8638745680363916939";
    LI.RUM.urls['boomerang-bw-img'] = "http://s.c.lnkd.licdn.com/scds/common/u/lib/boomerang/0.9.edge.4ab208445a/img/";
    
    
    
    LI.RUM.serverStartTime = 1379926319.114*1000;
    
    
    LI.RUM.enabled = true;
    YEvent.on(window, 'load', function() {
      YAHOO.util.Get.script(
      
        
            
              
              
                ["http://s.c.lnkd.licdn.com/scds/concat/common/js?h=ed29nkjpsa16bhrjq4na16owq-98wkc8drte3f4sgowwihu52bc-cxf4wsvkntx8ipnbh8aw32ci5-bntxs37tllhamgkqo8dp140n4-ej0bu8dhge4a5yggpk9bkobg0-2e50soneky56rf7x4eqnd3iqq&fc=2"]
              
            
          
        
      
    [0]);
    });
  </script>



<script type="text/javascript">
 if ( window.LI && LI.showAllDeferredImg && !LI.imgDeferFoldCheckDone ) { 
 LI.showAllDeferredImg( null, false );
 }
</script>



          

          
            
          
        
      
      
      
      
        
      
    
      
        

        
          <script id="localChrome"></script>
        
      
    
  
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


      
    
  
      
      

      
        
      







    <script type="text/javascript">
      var _gaq = _gaq || [];
      _gaq.push(['_setAccount', 'UA-3242811-1']);
      _gaq.push(['_setDomainName', '.linkedin.com']);
      _gaq.push(['_trackPageview', 'nprofile-public-success']);
      _gaq.push(['_setVar', 'guest']);
      
      
      YEvent.on( window, 'load', function() {
        YAHOO.util.Get.script("http://www.google-analytics.com/ga.js");
      });
    </script>
  

  





<script type="text/javascript">/* <![CDATA[ */
(function() {

  var bcookie = escape( LI.readCookie("bcookie") ),
    newTrkInfo = '2031957,' + document.referrer.substr(0,128),
    alias_secure = 'https://www.linkedin.com/analytics/noauthtracker?type=leo%2EpageTracking&pageType=full_page&pageKey=nprofile_public_jsbeacon&trkInfo=REPLACEME',
    alias_normal = '/analytics/noauthtracker?type=leo%2EpageTracking&pageType=full_page&pageKey=nprofile_public_jsbeacon&trkInfo=REPLACEME',
    is_secure = false,
    url = (is_secure) ? alias_secure : alias_normal;

  url = url.replace("REPLACEME", newTrkInfo);

  if (bcookie) {
    if(window.$ && $.ajax){
      $.ajax(url);
    } else {
      YAHOO.util.Connect.asyncRequest( 'get', url, {} );
    }
  }

})();
/* ]]> */</script>

  
      
        
      
      
      
      
        
      
    
      
      
    
      
      
    
      
      
    
      
      
    
      
      
      
      
      
      
      <script type="text/javascript">
        
          
      
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
          
            
              
      
    
            
          
        
        LI_WCT([
        
          
            
              "control-http-12248-9141289-1",
            
          
        
          
            
              "control-http-12248-9141290-2",
            
          
        
          
            
              "control-http-12248-9141291-3",
            
          
        
          
            
              "control-http-12248-9141291-4",
            
          
        
          
            
              "control-http-12248-9141291-5",
            
          
        
          
            
              "control-http-12248-9141292-6",
            
          
        
          
            
              "control-http-12248-9141292-7",
            
          
        
          
            
              "control-http-12248-9141293-8",
            
          
        
          
            
              "control-http-12248-9141293-9",
            
          
        
          
            
              "control-http-12248-9141293-10",
            
          
        
          
            
              "control-http-12248-9141294-11",
            
          
        
          
            
              "control-http-12248-9141294-12",
            
          
        
          
            
              "control-http-12248-9141300-13",
            
          
        
          
            
              "control-http-12248-9141302-14",
            
          
        
          
            
              "control-http-12248-9141302-15",
            
          
        
        ]);
      
    
          
            
          
        
        
      </script>
      
      
      
      
    
      
        

        
          
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



<script type="text/javascript">LI.Controls.processQueue();</script>





 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 
 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


<script type="text/javascript">
  LI.define('Tracking.Quantcast');
  LI.Tracking.Quantcast = function() {
    _qoptions = { qacct:"p-b3sGjMtCFrexE" };
    YAHOO.util.Get.script( 'http://edge.quantserve.com/quant.js' );
  };
  YEvent.on( window, 'load', LI.Tracking.Quantcast);
</script>
<noscript>
  <a href="http://www.quantcast.com/p-b3sGjMtCFrexE" target="_blank"><img src="http://pixel.quantserve.com/pixel/p-b3sGjMtCFrexE.gif" style="display: none;" height="1" width="1" alt=""/></a>
</noscript>

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    


<script type="text/javascript">
  LI.define('Tracking.Comscore');
  LI.Tracking.Comscore = function() {
    YAHOO.util.Get.script( 'http://b.scorecardresearch.com/beacon.js', {
      onSuccess: function() {
        COMSCORE.beacon({ c1:2, c2:6402952, c3:"", c4:"", c5:"", c6:"", c15:"" });
      }
    });
  };
  YEvent.on( window, 'load', LI.Tracking.Comscore);
</script>
<noscript>
  
      <img src="http://b.scorecardresearch.com/b?c1=2&amp;c2=6402952&amp;c3=&amp;c4=&amp;c5=&amp;c6=&amp;c15=&amp;cv=1.3&amp;cj=1" style="display:none" width="0" height="0" alt="" />
    
</noscript>

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
    
<script type="text/javascript">
  YEvent.on( window, 'load', function() {
    (function () {
      var protocol = 'http:';
      var d = new Image(1, 1);
      d.onerror = d.onload = function () { d.onerror = d.onload = null; };    
      d.src = [
        protocol,
        "//secure-us.imrworldwide.com/cgi-bin/m?ci=us-603751h&cg=0&cc=1&si=", 
        escape(window.location.href), "&rp=", 
        escape(document.referrer),   
        "&ts=compact&rnd=", 
        (new Date()).getTime()
      ].join('');
    })();
  });
</script>
<noscript>
  
      <img src="http://secure-us.imrworldwide.com/cgi-bin/m?ci=us-603751h&cg=0&cc=1&ts=noscript"
    width="1" height="1" alt="" style="display:none"/>
    
</noscript>


 
 



 </body>
</html>

          
        
      
      
      
      
        
      
    
    














